Skip to main content

Table 3 Baseline characteristics of the 101 hypertensive patients with or without arterial stiffness

From: Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients

Characteristic

Low arterial stiffness group (%)

High arterial stiffness group (%)

P value

Gender

 Male

19 (65.5)

48 (66.7)

0.912

 Female

10 (34.5)

24 (33.3)

Diabetes

 No

21 (72.4)

36 (50.0)

<0.001*

 Yes

8 (27.6)

36 (50.0)

Metabolic syndrome

 No

22 (75.9)

16 (22.2)

<0.001*

 Yes

7 (24.1)

56 (77.8)

ACE inhibitor use

 No

17 (58.6)

47 (65.3)

0.530

 Yes

12 (41.4)

25 (34.7)

ARB use

 No

14 (48.3)

31 (43.1)

0.633

 Yes

15 (51.7)

41 (56.9)

β-blocker use

 No

12 (41.4)

33 (45.8)

0.684

 Yes

17 (58.6)

39 (54.2)

CCB use

 No

15 (51.7)

42 (58.3)

0.544

 Yes

14 (48.3)

30 (41.7)

Thiazide use

 No

23 (78.3)

57 (79.2)

0.987

 Yes

6 (20.7)

5 (20.8)

Statin

 No

12 (41.4)

31 (43.1)

0.877

 Yes

17 (58.6)

35 (56.9)

 

Fibrate

 No

23 (79.3)

64 (88.9)

0.208

 Yes

6 (20.7)

5 (11.3)

 
  1. Data are expressed as number of patients and analysis was performed by using the Chi square test
  2. ARB angiotensin-receptor blocker, ACE angiotensin-converting enzyme, CCB calcium-channel blocker
  3. * P < 0.05 was considered statistically significant